Lily, Inc.
Lily, Inc., a prominent player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2010, the company has rapidly established itself as a leader in innovative healthcare solutions, particularly in the fields of personalised medicine and advanced therapeutics. Lily, Inc. is renowned for its cutting-edge products, including biologics and targeted therapies, which are designed to address complex health challenges. What sets them apart is their commitment to research and development, ensuring that their offerings are not only effective but also tailored to individual patient needs. With a strong market position, Lily, Inc. has achieved significant milestones, including multiple FDA approvals and partnerships with leading research institutions, solidifying its reputation as a trusted name in the biotechnology industry.
DitchCarbon Score
How does Lily, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lily, Inc.'s score of 21 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lily, Inc.'s reported carbon emissions
In 2021, Lily, Inc. reported total carbon emissions of approximately 159,000,000 kg CO2e from Scope 1, 551,000,000 kg CO2e from Scope 2, and 176,000,000 kg CO2e from Scope 3. This marked a significant reduction in emissions compared to previous years, with Scope 1 emissions decreasing from about 220,000,000 kg CO2e in 2018, Scope 2 from 745,000,000 kg CO2e, and Scope 3 from 266,000,000 kg CO2e. Lily, Inc. has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The company has reported a consistent decrease in emissions intensity over the years, indicating a proactive approach to sustainability. The emissions intensity related to greenhouse gases was approximately 0.032 in 2021, down from 0.041 in 2018, showcasing improvements in operational efficiency. While no formal climate pledges or SBTi (Science Based Targets initiative) reduction targets have been established, Lily, Inc. continues to monitor and report its emissions across all scopes, reflecting an ongoing commitment to addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Scope 1 | 220,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 745,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 266,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lily, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
